The effect of carbonic anhydrase inhibition on the velocity of thrombin-stimulated platelet aggregation under physiological conditions

Biochem Biophys Res Commun. 1984 May 31;121(1):266-70. doi: 10.1016/0006-291x(84)90717-4.

Abstract

We have studied the effect of ethoxzolamide , a specific carbonic anhydrase inhibitor, on the velocity of thrombin-stimulated platelet aggregation. After preincubation of platelet rich plasma with 10(-6) M ethoxzolamide the velocity of platelet aggregation was reduced by about 40%. Between 10(-11) M and 10(-10)M ethoxzolamide was necessary to achieve a half-maximal diminution of the aggregation velocity. An identical maximal reduction of the velocity of aggregation as with ethoxzolamide could be achieved by a nearly complete removal of CO2 from the platelet rich plasma. These results suggest that the intracellular CO2 hydration-dehydration reaction is involved in the activation of human platelets by thrombin. It is possible that the cytosolic carbonic anhydrase of platelets provides a rapid source of the protons that are transferred across the plasma membrane during the activation process.

MeSH terms

  • Blood Platelets / enzymology*
  • Carbonic Anhydrases / blood
  • Carbonic Anhydrases / physiology*
  • Cytosol / enzymology
  • Ethoxzolamide / pharmacology
  • Humans
  • Kinetics
  • Platelet Aggregation / drug effects*
  • Thrombin / antagonists & inhibitors
  • Thrombin / pharmacology*

Substances

  • Thrombin
  • Carbonic Anhydrases
  • Ethoxzolamide